Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment Phase of Cell Therapy Manufacturing
GenScript Bio Global Forum 2024 to Commence Vitality into GCT Industry
GenScript Named a BioSpace 2024 Best Place to Work
PISCATAWAY, N.J., Sept. 18, 2023 /PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its IVT mRNA synthesis portfolio with the addition of customized circular RNA (circRNA) and lipid nanoparticles (LNPs) formulation services. These new contract-manufactured reagent services are available immediately as part of GenScript's commitment to provide cutting-edge reagents that advance research in fields such as vaccine development, protein replacement therapies, and gene and cell therapy.
PISCATAWAY, N.J., Aug. 8, 2023 /PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has ramped up production of complex and modified peptides at its state-of-the-art cGMP manufacturing facility in Zhenjiang, China. A new, one-stop service offers neoantigen and peptide active pharmaceutical ingredients (API) adapted for large-scale manufacturing. To help drug-development teams shorten their time to market, GenScript also offers expert consulting support for CMC filing documents and the development of global regulatory strategies for new peptide drugs.
PISCATAWAY, N.J., July 20, 2023 /PRNewswire/ -- GenScript USA Inc., the world's leading life-science research tools and services provider, announced its third annual GenScript Gene & Cell Engineering Virtual Summit, which will feature in-depth discussions and research presentations on the crucial gene-synthesis and cell-editing technologies that are transforming scientific and biomedical research today.
GenScript Biotech Corporation, a provider of life-science research tools and services, has expanded its cGMP manufacturing capacity for sgRNA and non-viral DNA payloads with a new, state-of-the-art facility in Zhenjiang, Jiangsu, China. The latest expansion provides biopharma companies and gene and cell therapeutic discovery startups with components needed to advance novel therapies from the bench to the clinic.
GenScript Biotech Corporation, a provider of life-science research tools and services, debuted its GenTitan Gene Fragments Synthesis service. The announcement was made at SynBioBeta 2023 in Oakland.
GenScript Biotech Corporation, a provider of life-science research tools and services, expanded its primary manufacturing facility for oligonucleotide and peptide production at Zhenjiang, Jiangsu, China.
GenScript Biotech Corp., a provider of life-science research tools and services, is partnering with Allozymes, a Singapore-based biotech startup, to dramatically accelerate the enzyme discovery and development process. GenScript will provide the mutant libraries construction and expression and Allozymes will provide ultra-high-throughput screening service for applications across various industries, including pharmaceuticals, cosmetics, and food and beverage.